张洹
胎肝造血和间充质干细胞增殖分化潜能的研究;靶向关键癌基因小分子核酸药物的研制。
个性化签名
- 姓名:张洹
- 目前身份:
- 担任导师情况:
- 学位:
-
学术头衔:
博士生导师
- 职称:-
-
学科领域:
基础医学
- 研究兴趣:胎肝造血和间充质干细胞增殖分化潜能的研究;靶向关键癌基因小分子核酸药物的研制。
张洹,男,1948年11月出生,现任暨南大学医学院血液病研究所所长、研究员、博士研究生导师,《中国实验血液学杂志》编委。1987年在军事医学科学院获得博士学位;1987-1993在第一军医大学任教;1993年在暨南大学医学院血液病研究所工作至今;1994-1995年在英国曼切斯特Paterson癌症研究所从事一年访问研究; 1997-2003年间暨南大学医学院副院长。获得部级成果两项(中国人民解放军科技奖二等和三等各一项),参加国家级特等奖研究工作;申报发明专利八项,四项已经授权;指导博士研究生毕业10人; 指导硕士毕业8人。主持和完成国家、广东省、广州市科技项目十余项。发表中英论文170篇。研究方向:胎肝造血和间充质干细胞增殖分化潜能的研究;靶向关键癌基因小分子核酸药物的研制。
-
主页访问
1550
-
关注数
0
-
成果阅读
121
-
成果数
3
【期刊论文】EFFECT OF ANTISENSE hTERT mRNA OLIGODEOXYNUCLEOTIDE ON TELOMERASE ACTIVITY OF LEUKEMIC CELLS
张洹, Y. ZHANG* and D.M. HE
Cell Biology International 2002, 26 (5)427-431,-0001,():
-1年11月30日
The effect of antisense hTERT mRNA oligodeoxynucleotide on telomerase activity of leukemia cells was explored and investigated in the present study. Telomerase activity was measured by the telomerase PCR ELISA assay kit (TRAP); hTERT mRNA expression by reverse transcription polymerase chain reaction (RT-PCR) assay and gel-image system, hTERT protein by immunochemistry and flowcytometry. Results showed Incubation of leukemic cells (HL-60 and K562 cell lines) with 10 mol/l AS PS-ODN would significantly reduce the their mRNA levels and in vitro expression of hTERT protein 24 h later, so that the telomerase activity would be significantly down-regulated or inhibited. In conlusion, the hTERT AS PS-ODN is an excellent inhibitor for telomerase activity.
antisense, telomerase, leukemia, hTERT (, hTERT,, human telomerase reverse trans, c, r, i, p, t, ase), .,
-
43浏览
-
0点赞
-
0收藏
-
0分享
-
92下载
-
0评论
-
引用
张洹, Zhang Yuan*, and He Dong Mei
The Hematology Journal (2002), 3, 201~205,-0001,():
-1年11月30日
Introduction: As reported previously, inhibition of telomerase activity with hTERT (human telomerase reverse transcriptase) mRNA AS PS-ODN (Antisense phosphorothioate oligodeoxynucleotide) could increase the effect for CDDP (cis-diamminedichloroplatinum, CDDP) to induce apoptosis of HL-60 and K562 leukemic cells. In these studies, this phenomenon will be further investigated and expanded to leukemia cells from acute and chronic myeloid leukemia (AML and CML). Materials and methods: Cell samples of AML and CML patients, from the first affiliated hospital of Jinan University Medical College, were obtained. The primary cell culture was established to investigate whether or not the inhibition of telomerase activity with hTERT mRNA AS PS-ODN increased the effect for cisplatin to induce apoptosis of leukemic cells from patients. Cell growth was observed with trypan blue dye exclusion. hTERT protein was determined by tissue chemistry and owcytometry. Telomerase activity was tested with the telomerase PCR ELISA assay kit (Boehringer Mannheim). Results: The inhibition of telomerase activity with hTERT mRNA AS PS-ODN could significantly increase the susceptibility of AML or CML cells to CDDP. The apoptotic percentage of cells (AML: 42.68%; CML: 35.72%) treated with AS PS-ODN/CDDP was significantly difierent from that of cells (AML, 29.02%; CML, 23.84%) treated with S PS-ODN/CDDP or CDDP. Conclusion: The inhibition of telomerase activity with hTERT mRNA AS PS-ODN could increase the effect for CDDP to induce apoptosis of leukemic cells from AML and CML patients.
telomerase, hTERT gene, leukemia, antisense, cis-diamminedichloroplatinum (, CDDP), , drug-sensitivity
-
28浏览
-
0点赞
-
0收藏
-
0分享
-
71下载
-
0评论
-
引用
【期刊论文】Effect of bcl-2 antisense oligodeoxynucleotides on drug sensitivity of leukemic cells
张洹, Yuan Zhang*, and Xiao Yong Lei
The Hematology Journal (2003) 4, 187-197,-0001,():
-1年11月30日
Introduction: We investigated the effect of two antisense oligodeoxynucleotides, previously selected with the help of computer-aided RNA structure prediction, on drug sensitivity, bcl-2 expression and apoptosis of leukemia cells. The drugs tested were etoposide (VP-16), cytarabine (Ara-C), daunorubicin (DNR) and arsenic trioxide (As2O3). Materials and methods: The experimental assays were performed with cultures, IC50 of leukemic cells to drugs, immunochemistry and flow cytometry. Results: The results showed that the two antisense oligodeoxynucleotides significantly reduced IC50 levels for VP-16, Ara-c, DNA and As2O3, inhibited bcl-2 gene expression and induced apoptosis of leukemic cells. Conclusions: Computational prediction of antisense efficacy is faster than other methods and more cost-efficient. This could hasten the development of sequences for both research and clinical applications.
antisense oligodeoxynucleotide (, AS-ODN), , bcl-2 gene, drug sensitivity, leukemia, computational prediction
-
50浏览
-
0点赞
-
0收藏
-
0分享
-
68下载
-
0评论
-
引用